Ibolya E. András
- Virology top 1%
- HIV Research and Treatment 21
- Neurology top 1%
- Barrier Structure and Function Studies 19
- Neuroinflammation and Neurodegeneration Mechanisms 7
- Neurological Disease Mechanisms and Treatments 4
- Biological Psychiatry top 10%
- Emergency Medicine top 5%
- Infectious Diseases top 10%
-
- Extracellular vesicles in disease 8
-
- Alzheimer's disease research and treatments 6
-
- Drug Transport and Resistance Mechanisms 5
-
- MicroRNA in disease regulation 3
Ibolya E. András
40 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 101
- Virology 578
- Neurology 685
- Biological Psychiatry 57
- Emergency Medicine 128
- Infectious Diseases 188
Countries citing papers authored by Ibolya E. András
This map shows the geographic impact of Ibolya E. András's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibolya E. András with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibolya E. András more than expected).
Fields of papers citing papers by Ibolya E. András
This network shows the impact of papers produced by Ibolya E. András. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibolya E. András. The network helps show where Ibolya E. András may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ibolya E. András, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 9 | |
| 3 | 2019 | 50 | |
| 4 | 2016 | 48 | |
| 5 | 2015 | 79 | |
| 6 | 2014 | 2 | |
| 7 | 2014 | 15 | |
| 8 | 2014 | 15 | |
| 9 | 2012 | 31 | |
| 10 | 2012 | 56 | |
| 11 | 2012 | 15 | |
| 12 | 2009 | 38 | |
| 13 | 2009 | 50 | |
| 14 | 2008 | 39 | |
| 15 | 2008 | 38 | |
| 16 | 2007 | 37 | |
| 17 | 2007 | 25 | |
| 18 | 2005 | 180 | |
| 19 | 2003 | 145 | |
| 20 | 1997 | 12 |
About Ibolya E. András
Ibolya E. András is a scholar working on Virology, Neurology, Physiology, Molecular Biology and Cancer Research, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), Barrier Structure and Function Studies (19 papers), Extracellular vesicles in disease (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Alzheimer's disease research and treatments (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Neurological Disease Mechanisms and Treatments (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Virology (578 citations), Neurology (685 citations), Biological Psychiatry (57 citations), Emergency Medicine (128 citations) and Infectious Diseases (188 citations). Ibolya E. András has collaborated with scholars based in United States, Hungary and Poland. Frequent co-authors include Michał Toborek, Bernhard Hennig, Hong Pu, Sung Yong Eum, Mária A. Deli, Avindra Nath, Wen Huang, Kentaro Hayashi, Jing Tian and Govinder Flora. Their work appears in journals such as Journal of Cerebral Blood Flow & Metabolism, The FASEB Journal, Journal of Neurochemistry, Molecular and Cellular Neuroscience and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.